Millstone Evans Group’s Gilead Sciences GILD Stock Holding History

Millstone Evans Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.9K	Buy	411 +43	+12%	+$5.67K	0.03%	338
2026 Q1	$51.3K	Buy	368 +49	+15%	+$6.86K	0.03%	320
2025 Q4	$39.2K	Hold	319	–	–	0.02%	376
2025 Q3	$35.4K	Buy	319 +118	+59%	+$13.4K	0.02%	384
2025 Q2	$22.3K	Hold	201	–	–	0.02%	429
2025 Q1	$22.5K	Hold	201	–	–	0.02%	433
2024 Q4	$18.6K	Buy	+201	New	+$18.1K	0.01%	428

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millstone Evans Group's GILD Position: Q2 2026 in Review

Millstone Evans Group increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $5.67K and bringing the position to 411 shares worth $51.9K. The position accounts for 0.03% of the portfolio, ranked #338.

Millstone Evans Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 1,926 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Millstone Evans Group held 411 shares of Gilead Sciences worth $51.9K as of Q2 2026.
Millstone Evans Group bought 43 Gilead Sciences shares in Q2 2026, an estimated $5.67K.
Gilead Sciences made up 0.03% of Millstone Evans Group's portfolio in Q2 2026, its #338 holding.
Millstone Evans Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
1,926 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.